Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €0.04 EUR
Change Today +0.001 / 2.38%
Volume 0.0
T2J On Other Exchanges
As of 3:08 AM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

taihua plc (T2J) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/7/15 - €0.05
52 Week Low
10/27/14 - €0.02
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TAIHUA PLC (T2J)

Related News

No related news articles were found.

taihua plc (T2J) Related Businessweek News

No Related Businessweek News Found

taihua plc (T2J) Details

Taihua plc, an investment holding company, manufactures and sells pharmaceutical products in the People’s Republic of China. The company operates through four segments: Paclitaxel, Homoharringtonine, Traditional Chinese Medicines (TCM) Products, and Forsythia. It develops, manufactures, and distributes active pharmaceutical ingredients, which comprise paclitaxel that is extracted from yew tree for the treatment of ovaries, breast, lungs, skin, and mucous membranes cancer; and Homoharringtonine, an alkaloid extracted from cephalotaxus tree for the treatment of acute myeloid leukaemia and other cancers. The company also develops, produces, distributes, and sells TCM products, including Gengnianan tablets for the treatment of symptoms of menopause; Duzhong Pingya tablets for use in the treatment of high blood pressure; Zaoren Anshen Keli for the treatment of insomnia and headaches caused by neurological problems; and Bunao Anshen tablets for the treatment of headaches, insomnia, and palpitation. Its TCM products also consist of Jiangzi Jianfei tablets for cholesterol and help weight loss; Dabaidu capsules for the treatment of urinary infection; Runing tablets for the treatment of pain of sore breasts; and Bian Tong Pian for the treatment of constipation. In addition, Taihua plc is involved in the cultivation, harvest, and sale of Forsythia, a flowering shrub for use as raw material in TCM preparations. The company was formerly known as China Natural Plc and changed its name to Taihua plc in September 2006. Taihua plc was incorporated in 2006 and is based in Xi'an, the People’s Republic of China.

83 Employees
Last Reported Date: 06/28/14
Founded in 2006

taihua plc (T2J) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: CNY108.0K
Executive Director
Total Annual Compensation: CNY108.0K
Vice General Manager and Executive Director
Total Annual Compensation: CNY108.0K
Compensation as of Fiscal Year 2013.

taihua plc (T2J) Key Developments

Taihua Plc Reports Sales Results for the Full Year Ended December 31, 2014

Taihua Plc reported sales results for the full year ended December 31, 2014. For the year, the company reported sales of RMB 53.1 million compared to RMB 52.3 million a year ago.

Taihua plc Announces Change of Address

Taihua Plc confirms that its registered office has been changed to 20 Fenchurch Street, London EC3M 3AG with immediate effect.

Taihua plc Announces Resignation of Liyi Chen as Director

Taihua Plc announced Professor Liyi Chen resigned as a director of the Company and Mr. Mingjian Yin, aged 31, was appointed as a director of the Company. Mr. Yin, is a director of Beijing Jinsanhuan Textile Import & Export Co., Limited. He is not and has not been in the last 5 years a director or partner of any other company or partnership.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
T2J:GR €0.04 EUR +0.001

T2J Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for T2J.
View Industry Companies

Industry Analysis


Industry Average

Valuation T2J Industry Range
Price/Earnings 16.5x
Price/Sales 0.5x
Price/Book 0.2x
Price/Cash Flow 16.5x
TEV/Sales 0.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TAIHUA PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at